HomeCMPX • NASDAQ
Compass Therapeutics Inc.
add
$2.46
0.40%
After Hours:(6.50%)+0.16
$2.62
Closed: Mar 14, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 16.57M | 7.67% |
Net income | -15.03M | -12.06% |
Net profit margin | — | — |
Earnings per share | -0.11 | 0.00% |
EBITDA | -16.43M | -7.89% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.72M | -16.88% |
Total assets | 140.40M | -10.50% |
Total liabilities | 15.17M | 81.96% |
Total equity | 125.23M | — |
Shares outstanding | 138.28M | — |
Price to book | 2.71 | — |
Return on assets | -28.62% | — |
Return on capital | -29.90% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.03M | -12.06% |
Cash from operations | -9.16M | 25.84% |
Cash from investing | 15.37M | 143.43% |
Cash from financing | -94.00K | 40.51% |
Net change in cash | 6.11M | 198.64% |
Free cash flow | -3.39M | 54.44% |
Previous close
$2.47
Day range
$2.45 - $2.67
Year range
$0.77 - $4.08
Market cap
338.47M USD
Avg Volume
940.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
35
